Literature DB >> 14981369

A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: two-year follow-up.

Karen L Ward1, Paul Hilton.   

Abstract

OBJECTIVE: This study was undertaken to compare tension-free vaginal tape (TVT) with colposuspension as the primary treatment for stress incontinence. STUDY
DESIGN: The trial was conducted in gynecology or urology departments in 14 centers in the United Kingdom and Ireland. Three hundred forty-four women with urodynamic stress incontinence were randomly assigned to groups: 175 to TVT and 169 to colposuspension. Patients were assessed using the Short Form-36 health status questionnaire, the Bristol Female Lower Urinary Tract Symptoms questionnaire, clinical examination, and a 1-hour perineal pad test. Unpaired and paired data were analyzed with the Wilcoxon rank sum and matched pairs tests, respectively, and proportions were compared with the Fisher exact test.
RESULTS: When data were analyzed on an intention-to-treat basis, assuming patients with missing data to be treatment failures, 63% of the TVT group and 51% of the colposuspension group were objectively cured at 2 years (odds ratio 1.67, 95% CI 1.09-2.58).
CONCLUSION: The TVT procedure appears to be as effective as colposuspension for the treatment of urodynamic stress incontinence at 2 years.

Entities:  

Mesh:

Year:  2004        PMID: 14981369     DOI: 10.1016/j.ajog.2003.07.029

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  104 in total

1.  Nerve injury: an exceptional cause of pain after TVT.

Authors:  Harry A M Vervest; Marlies Y Bongers; Anneke A M van der Wurff
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-22

2.  The prevalence of voiding difficulty after TVT, its impact on quality of life, and related risk factors.

Authors:  Harry A M Vervest; Tanya M Bisseling; A Peter M Heintz; Steven E Schraffordt Koops
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-22

3.  One-year results of a prospective randomized, evaluator-blinded, multicenter study comparing TVT and TVT Secur.

Authors:  Maria Andrada Hamer; Per-Göran Larsson; Pia Teleman; Christina Eten Bergqvist; Jan Persson
Journal:  Int Urogynecol J       Date:  2012-06-16       Impact factor: 2.894

4.  Short periods of observation.

Authors:  Jens W Bagner; Bernd Klosterhalfen; Thomas Otto
Journal:  Dtsch Arztebl Int       Date:  2010-11-26       Impact factor: 5.594

5.  Efficacy and safety of TVT-O and TVT-Secur in the treatment of female stress urinary incontinence: 1-year follow-up.

Authors:  Giovanni A Tommaselli; Costantino Di Carlo; Virginia Gargano; Carmen Formisano; Mariamaddalena Scala; Carmine Nappi
Journal:  Int Urogynecol J       Date:  2010-05-26       Impact factor: 2.894

Review 6.  Pelvic Prolapse Repair in the Era of Mesh.

Authors:  Natalie Gaines; Priyanka Gupta; Larry T Sirls
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

7.  TVT vs TOT: a case controlled study in patients with mixed urodynamic stress incontinence and detrusor overactivity.

Authors:  Jonathan R A Duckett; Maya Basu
Journal:  Int Urogynecol J       Date:  2010-02-24       Impact factor: 2.894

8.  Anatomical study of the obturator foramen and dorsal nerve of the clitoris and their relationship to minimally invasive slings.

Authors:  Chahin Achtari; Bayden J McKenzie; Richard Hiscock; Anna Rosamilia; Lore Schierlitz; Chris A Briggs; Peter L Dwyer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-10-07

9.  Two-Year Results of Burch Compared With Midurethral Sling With Sacrocolpopexy: A Randomized Controlled Trial.

Authors:  Emanuel C Trabuco; Brian J Linder; Christopher J Klingele; Roberta E Blandon; John A Occhino; Amy L Weaver; Michaela E McGree; John B Gebhart
Journal:  Obstet Gynecol       Date:  2018-01       Impact factor: 7.661

10.  Pelvic floor consequences of cesarean delivery on maternal request in women with a single birth: a cost-effectiveness analysis.

Authors:  Xiao Xu; Julie S Ivy; Divya A Patel; Sejal N Patel; Dean G Smith; Scott B Ransom; Dee Fenner; John O L Delancey
Journal:  J Womens Health (Larchmt)       Date:  2010-01       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.